Don't Miss Out On Great Gains! - Best Investment Newsletter


Don't miss out! Subscribe Now

Search For More

Wednesday, December 16, 2015

AGEN Agenus Inc. up 12% on New Buy Rating

Nice jump today for Agenus Inc. (NASDAQ: AGEN)  on this news:

Jefferies Starts Agenus Inc. (AGEN) at Buy; Sees 100% Upside
December 16, 2015 7:54 AM EST 

Jefferies initiates coverage on Agenus Inc. with a Buy rating and a price target of $8.00.

Analyst Biren Amin commented, 
"Agenus is developing a comprehensive Immuno-Oncology (IO) platform consisting of multiple checkpoints both fully owned and through partnerships and could be a leader in cancer vaccine development through the deployment of its QS-21 adjuvant which could increase the efficacy of cancer vaccines. AGEN is also partnered with Merck and Incyte across 9 novel IO programs totaling >$450M in milestones. Therefore, AGEN's $130M EV offers significant upside, in our view."


Learn my "Core and Explore" approach to investing
with "Kirk Lindstrom's Investment Letter"
Don't miss out! Subscribe Now
I have a very generous Refund Policy 

Kirk Lindstrom's Investment Letter Performance

Followers (New)